Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.32
    OpenPayerPolicy UpdatesClinical/Medical PolicyWPS Health Insurance Stimulator Coverage | OpenPay…
    Ask Trek AI about this page
    CurrentWPS Health InsurancePolicy 250-0023-1812

    Spinal Cord and Peripheral Nerve Stimulators Medical Guideline

    Customize your policy alerts

    Sign up for WPS Health Insurance Policy 250-0023-1812 alerts

    Get alerted when Policy 250-0023-1812 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This guideline governs medical necessity and coverage criteria for spinal cord stimulators, peripheral nerve stimulation methods, and related electrical stimulation devices. Coverage varies by member benefit plan and is subject to plan terms, applicable exclusions, state and federal law, and medical necessity requirements.

    Policy Summary
    PayerWPS Health Insurance
    PolicySpinal Cord and Peripheral Nerve Stimulators Medical Guideline
    Policy CodePolicy 250-0023-1812
    Change TypeNo material change
    Effective DateJul 1, 2026
    Next Review DateN/A
    Key ActionBefore an initial spinal cord stimulator trial, document failed 6-week physical therapy or chiropractic treatment and 3-month medication therapy trials within the preceding 12 months.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    3-7 daysTrial duration
    50%+Pain improvement for permanent placement
    7 yearsBattery replacement timing
    9Initial trial conditions

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    RequiredFDA approval requirement

    Coverage Criteria

    Initial spinal cord stimulator trial

    Covered as medically necessary when ALL of the following are met.

    Initial short-term spinal cord stimulator trial

    • Qualifying pain indication: Chronic ischemic or chronic neuropathic pain due to failed back surgery syndrome, complex regional pain syndrome, critical limb ischemia causing leg pain at rest, or diabetic peripheral neuropathy.

      Complex regional pain syndrome was previously referred to as reflex sympathetic dystrophy.

    • Psychological evaluation: A mental health provider determines that there is no uncontrolled mental health condition that could affect pain perception, contraindicate spinal stimulation, or affect treatment success.
    • Failed conservative treatment: Within the past 12 months, a 6-week trial of physical therapy or chiropractic treatment and a 3-month trial of medication therapy have failed.6 weeks of PT or chiropractic treatment; 3 months of medication therapy

      For failed back surgery syndrome, both trials must have occurred after surgery.

    • Surgical assessment: Surgery is contraindicated, has failed, or is considered inappropriate after surgical consultation for spinal surgery or revascularization for critical limb ischemia.

      Surgical consultation is not required for complex regional pain syndrome or diabetic peripheral neuropathy.

    • Patient capability: The individual is able to operate the stimulator appropriately.
    • Cardiac device assessment: The individual does not have an implantable defibrillator or cardiac pacemaker; cardiac documentation is required.
    • Pregnancy status: The individual is not pregnant.
    • Bleeding risk: The individual has no uncontrolled coagulopathy or severe thrombocytopenia.
    • Infection status: There is no active systemic or local infection.

    Permanent spinal cord stimulator placement

    Covered as medically necessary when BOTH of the following are met.

    • Prior trial qualification: The individual met all indications of coverage for the temporary spinal cord stimulator trial.
    • Successful trial response: During a dorsal column electrical spinal stimulator test period of at least 3 days, the individual experienced improvement in pain of 50% or more and improved functional ability or activity level.At least 50% pain improvement; test period of at least 3 days

      Both pain improvement and functional improvement are required.

    Replacement spinal cord stimulator

    Covered as medically necessary when prior pain relief occurred and ONE of the following is met.

    Spinal cord stimulator replacement

    • Qualifying replacement circumstance: The existing device is malfunctioning and cannot be repaired; the battery is approaching end of life and at least 7 years have elapsed, depending on the manufacturer; the warranty has expired; or the device was explanted because of suspected infection that has resolved.At least 7 years for battery end of life, depending on manufacturer

    FES and NMES

    Covered as medically necessary when EITHER qualifying indication is met.

    FES/NMES indications

    • Post-stroke foot drop: After stroke, the patient has hemiplegia or hemiparesis with foot drop; stroke onset was more than 3 months earlier; the patient is cognitively able to understand and comply with the rehabilitation protocol; and ankle range of motion is within the limits required for normal gait.Stroke onset greater than 3 months prior

      All post-stroke subcriteria are required.

    • Heart failure: New York Heart Association grade III or IV heart failure.NYHA class III or IV

    Other peripheral nerve stimulation

    Other peripheral nerve stimulation methods are not covered as established medically necessary services.

    Experimental peripheral stimulation methods: Other methods of peripheral nerve stimulation are considered experimental, investigational, and unproven for all indications, including peripheral nerve stimulation (PNS), percutaneous electrical nerve stimulation (PENS), peripheral subcutaneous field stimulation (PSFS), peripheral nerve field stimulation (PNFS), transcutaneous electrical nerve stimulation (TENS), percutaneous neuromodulation therapy (PNT), and transcutaneous electrical modulation pain reprocessing (TEMPR).

    For percutaneous tibial nerve stimulation, refer to MCG A0699. For sacral nerve stimulation for urinary incontinence or urgency, refer to MCG A-0645.

    The guideline excludes or classifies as experimental, investigational, and unproven several stimulation approaches, devices, and indications. These include dorsal root ganglion or dorsal ramus stimulation, specified cervical spinal cord stimulation uses, cranial electrical stimulation for posttraumatic stress disorder, stimulation for idiopathic neuropathy, phantom limb pain, or post-herpetic neuralgia, use of devices not approved by the FDA, and concurrent use of more than one dorsal column electrical spinal stimulator. Other listed peripheral, cranial, sacral, vagal, tibial, and electrical stimulation methods are also subject to the guideline’s limitations.

    Replacement of functioning leads or electrodes is not medically necessary. Lead or electrode replacement is generally not required when replacing a generator because of battery end of life; replacement is covered only when the applicable qualifying replacement circumstances and prior pain relief requirements are met.

    Replacement of a functioning standard, non-high-frequency dorsal column stimulator with a high-frequency dorsal column stimulator is considered not medically necessary.

    Replacement of a functioning generator with an alternative brand is considered not medically necessary.

    Use or placement of a cervical, lumbar, or thoracic dorsal column electrical spinal stimulator for persistent radiculopathy without a history of failed surgery is considered not medically necessary.

    Use for a condition or diagnosis listed in the guideline but without meeting the applicable coverage criteria is considered not medically necessary. A condition or diagnosis not listed among the indications of coverage is considered experimental, investigational, and unproven.

    Coding and Operational Thresholds

    Referenced external guidelinemixed
    MCG A0699Percutaneous Tibial Nerve Stimulation
    Referenced external guidelinemixed
    MCG A-0645Implanted Electrical Stimulator, Sacral Nerve
    Spinal Cord Stimulation Trial
    Trial duration3-7 days
    DeviceOne spinal cord stimulator
    Eligible spinal levelsCervical, lumbar, or thoracic
    Conservative Treatment Trial
    TreatmentPhysical therapy or chiropractic treatment
    Trial duration6 weeks
    Required timeframeWithin the past 12 months; the trial must have failed

    Provider Actions and Documentation

    Prior Authorization

    Verify Plan Requirements Before Submission

    Before providing or requesting spinal cord or peripheral nerve stimulation, review the member’s applicable benefit plan, contract, and endorsements. Confirm coverage details, exclusions, benefit requirements, network status, and whether prior authorization is required; this guideline does not guarantee payment.

    • Coverage varies by plan and is subject to the applicable benefit plan, contract, exclusions, limitations, and state and federal law.
    • Contact the customer service number on the member ID card for plan-specific benefit and authorization information.
    Step Therapy

    Document Conservative Treatment Trials

    For an initial cervical, lumbar, or thoracic spinal cord stimulation trial, document that required conservative treatment has failed within the applicable timeframe.

    • Document a failed 6-week trial of physical therapy or chiropractic treatment within the past 12 months.

    Background

    Electrical nerve stimulators are used primarily to manage chronic intractable pain. They include central nervous system or spinal cord stimulators and peripheral nerve stimulators. Spinal cord stimulation places electrodes in the epidural space and connects them to an implanted pulse generator; traditional systems may produce paresthesia, while high-frequency systems typically do not. Peripheral techniques vary according to whether electrodes are implanted, placed in subcutaneous tissue, delivered through the skin, or inserted percutaneously.

    Definitions

    Spinal Cord Stimulator
    Device typeImplanted device
    FunctionDelivers electrical impulses for pain management or to alter the perception of pain
    Electrode and generator placementElectrodes are placed in the epidural space and connected to a surgically implanted pulse generator
    Peripheral Nerve Stimulation (PNS)
    ProcedureElectrodes are surgically implanted
    Electrode locationAdjacent to a targeted peripheral nerve
    TargetA specific peripheral nerve

    Required Conservative Treatment Before Trial

    Failed conservative treatment before initial spinal cord stimulator trial

    Before an initial spinal cord stimulator trial, BOTH failed conservative treatment requirements must be documented.

    • Physical therapy or chiropractic treatment: A 6-week trial of physical therapy or chiropractic treatment has failed.6 weeks within the past 12 months
    • Medication therapy: A 3-month trial of medication therapy has failed.3 months within the past 12 months

    Imaging Requirements

    Note

    No specific imaging requirement stated

    The guideline does not state a specific imaging requirement for a spinal cord stimulator trial. Ensure that the other applicable medical-necessity and documentation requirements are addressed.

    Note

    No specific imaging requirement stated

    The guideline does not state a specific imaging requirement for a spinal cord stimulator trial. Ensure that the other applicable medical-necessity and documentation requirements are addressed.

    Not Covered

    The guideline does not cover or considers investigational the following approaches and uses: dorsal root ganglion or dorsal ramus stimulation; cervical spinal cord stimulation for the specifically listed noncovered indications; implantable peripheral nerve stimulation for chronic pain; and TENS for any indication. It also identifies dorsal column stimulation for phantom limb pain, post-herpetic neuralgia, or idiopathic neuropathy, as well as numerous other peripheral, cranial, sacral, vagal, tibial, and electrical stimulation methods, as experimental, investigational, and unproven or otherwise limited under the guideline.

    Policy Summary
    PayerWPS Health Insurance
    PolicySpinal Cord and Peripheral Nerve Stimulators Medical Guideline
    Policy CodePolicy 250-0023-1812
    Change TypeNo material change
    Effective DateJul 1, 2026
    Next Review DateN/A
    Key ActionBefore an initial spinal cord stimulator trial, document failed 6-week physical therapy or chiropractic treatment and 3-month medication therapy trials within the preceding 12 months.
    SourceLink
    On This Page
    Coverage CriteriaCoding and Operational ThresholdsProvider Actions and DocumentationBackgroundDefinitionsRequired Conservative Treatment Before TrialImaging RequirementsNot Covered
    Conservative Treatment Trial
    TreatmentMedication therapy
    Trial duration3 months
    Required timeframeWithin the past 12 months; the trial must have failed
    Permanent Placement Test Response
    Pain responseImprovement in pain of 50% or more
    Functional responseImproved functional ability or activity level
    Test periodAt least 3 days
    Battery Replacement Timing
    Replacement circumstanceImpending end of battery life
    Elapsed timeAt least 7 years
    Timing qualificationDepending on the manufacturer
  1. Document a failed 3-month medication therapy trial within the past 12 months.
  2. For failed back surgery syndrome, both trials must have occurred after the surgery.
  3. Unsupported block type: documentation

    Documentation Required

    Document Replacement Justification

    For a replacement spinal cord stimulator, document prior pain relief from the device and the specific reason replacement is necessary. Include evidence of malfunction and inability to repair, impending battery end of life, warranty expiration, or explantation for suspected infection that has resolved, as applicable.

    • Document manufacturer-dependent battery end of life, generally at least 7 years where applicable.
    • Replacement of functioning leads or electrodes is generally not medically necessary and is not normally required for generator replacement due to battery end of life.
    • A functioning generator replacement with an alternative brand, or replacement of a functioning standard stimulator with a high-frequency stimulator, is not medically necessary.
    Billing Rule

    Submit Correct Coding

    Use correct coding for the item or service and ensure the coding complies with all applicable coding guidelines.

    • Submit coding that accurately reflects the device, service, indication, and replacement circumstances.
    Prior Authorization

    Verify Benefits and Authorization

    Recheck the member’s benefit plan, contract, endorsements, exclusions, prior authorization requirements, and limitations for each request. Coverage is subject to the current applicable plan terms and may differ from the guideline’s medical-necessity criteria.

    • Confirm benefit and network status before scheduling or delivering services.
    • Obtain prior authorization when required by the plan.
    • Do not treat guideline listing as plan authorization or a guarantee of payment.
    Denial Risk

    Unlisted Indication Is Unproven

    If the requested condition or diagnosis is not listed under the guideline’s Indications of Coverage, treat the use as experimental, investigational, and unproven to affect health outcomes.

    • Confirm that the diagnosis and requested stimulation approach match a listed covered indication before submission.
    Denial Risk

    Criteria Not Met: Not Medically Necessary

    If the condition is listed but the required coverage criteria are not met, the service is considered not medically necessary.

    • For an initial trial, verify the required diagnosis, psychological evaluation, conservative treatment failures, surgical consultation requirements or exceptions, ability to operate the device, cardiac-device documentation when applicable, nonpregnancy, and absence of uncontrolled coagulopathy, severe thrombocytopenia, and active infection.
    • For permanent placement, verify that the temporary trial criteria were met and that the trial produced at least 50% pain improvement with improved functional ability or activity during a test period of at least 3 days.
    Denial Risk

    Check Excluded Stimulation Approaches and Indications

    Do not submit excluded stimulation approaches or indications as covered spinal cord stimulation. These uses are experimental, investigational, and unproven, or otherwise not medically necessary under the guideline.

    • Dorsal root ganglion and dorsal ramus stimulation are experimental, investigational, and unproven.
    • Cervical spinal cord stimulation for cervical trauma, disc herniation, essential tremor, failed cervical spine surgery syndrome with arm pain or neck pain, cervicogenic headache, gliomas, migraine, radiation-induced brain injury, stroke, trigeminal neuropathy, or other unlisted indications is experimental, investigational, and unproven.
    • Persistent radiculopathy without a history of failed surgery is not medically necessary.
    Denial Risk

    Screen Experimental Devices and Methods

    Screen the request for non-FDA-approved devices and alternative, peripheral, cranial, sacral, vagal, tibial, TENS, FES/NMES, and other electrical stimulation methods that the guideline identifies as experimental, investigational, and unproven.

    • Non-FDA-approved devices are experimental, investigational, and unproven.
    • Examples include MENS, MET, IFT, PES, PEMF, MPT, noninvasive peroneal nerve stimulation, specified peripheral nerve stimulation, tAN, PENFS, electroanalgesia/interferential current therapy, Alpha-Stim, and the Freedom Spinal Cord Stimulator System for chronic back pain.
    • TENS is unproven for any indication; FES/NMES is unproven except for the specifically covered post-stroke foot-drop and NYHA grade III or IV heart-failure indications.
    • Specified sacral, vagal, and implantable tibial nerve stimulation uses are experimental, investigational, and unproven.
    Denial Risk

    Check Replacement Exclusions

    Do not submit noncovered replacement requests involving functioning components or an upgrade or brand change that the guideline excludes.

    • Replacement of functioning leads or electrodes is not medically necessary.
    • Replacement of a functioning standard dorsal column stimulator with a high-frequency dorsal column stimulator is not medically necessary.
    • Replacement of a functioning generator with an alternative brand is not medically necessary.
    Denial Risk

    Multiple Concurrent Stimulators Are Unproven

    Do not request or place more than one dorsal column electrical spinal stimulator concurrently. Concurrent use or placement of multiple dorsal column electrical spinal stimulators is experimental, investigational, and unproven.

    • Verify that the requested device is not being used or placed concurrently with another dorsal column electrical spinal stimulator.
    Denial Risk

    Check Excluded Pain Indications

    Screen the diagnosis carefully because several pain indications are excluded or unproven under the guideline. Do not submit these indications as covered without confirming an applicable benefit or policy exception.

    • Idiopathic neuropathy is experimental, investigational, and unproven.
    • Management of phantom limb pain or post-herpetic neuralgia with spinal cord stimulation is excluded as experimental, investigational, and unproven.
    • An implantable peripheral nerve stimulator for chronic pain is investigational for all indications.
    • Other listed excluded or unproven chronic pain uses include TENS, specified alternative stimulation methods, and FES/NMES indications outside those specifically covered.
    PNFS/PSFS
    TermsPeripheral nerve field stimulation (PNFS) and peripheral subcutaneous field stimulation (PSFS)
    Lead placementElectrode leads are placed in the subcutaneous tissue around the painful area
    TargetA group of nerves in the field of pain rather than one specific nerve
    Transcutaneous Electrical Nerve Stimulation (TENS)
    Delivery methodElectrical impulses are delivered to the surface of the skin
    Treatment siteThe site of pain
    ImplantationThe device is not typically surgically implanted
    Percutaneous Electrical Nerve Stimulation (PENS)
    Delivery methodElectrical impulses are delivered via needle electrodes inserted into the skin
    Electrode locationAdjacent to the nerves serving the painful area
    ImplantationElectrodes are not implanted
    Percutaneous Neuromodulation Therapy (PNT)
    Delivery methodElectrical impulses are delivered through electrode arrays inserted directly into deep tissues
    Treatment siteNear the area causing the pain
    ImplantationElectrodes are not implanted
    Failed Back Surgery Syndrome
    AbbreviationFBSS
    MeaningFailed back surgery syndrome
    Pain contextA listed cause of chronic ischemic or chronic neuropathic pain for a spinal cord stimulation trial